Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 2998-3005, September 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grieder, A.
Right arrow Articles by Stähelin, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grieder, A.
Right arrow Articles by Stähelin, H.

Comparative Study of Early Effects of Epipodophyllotoxin Derivatives and Other Cytostatic Agents on Mastocytoma Cultures

Alfons Grieder1, Richard Maurer and Hartmann Stähelin

Biological and Medical Research Division, Sandoz Ltd., CH-4002 Basel, Switzerland

The effects of various cytostatic agents (mechlorethamine, 1-ß-D-arabinofuranosylcytosine, 6-mercaptopurine, methotrexate, colchicine, vincristine, a podophyllotoxin derivative, bleomycin, 1,2-bis(3,5-dioxopiperazin-1-yl)propane, the epipodophyllotoxin derivatives 4'-O-demethyl-1-O-[4,6-O-2-thenylidene-ß-D-glucopyranosyl]epipodophyllotoxin and 4'-O-demethyl-1-O-[4,6-O-ethylidene-ß-D-glucopyranosyl]epipodophyllotoxin, and X-rays) on cell proliferation, mitotic index, cellular DNA, RNA, and protein content and on the incorporation of their respective isotope-labeled precursors were studied in cultures of mastocytoma cell line P-815X2 during the first 6 hr of exposure to the various agents.

Most of these agents exhibited effects compatible with their accepted mechanisms of action. An exception to this was the finding that 1-ß-D-arabinofuranosylcytosine depressed the mitotic index to less than one-half of the control value within 90 min of drug addition; this effect is not compatible with an exclusive action in G1 or S phase of the cell cycle, but it suggests an additional block in G2.

The two epipodophyllotoxin derivatives 4'-O-demethyl-1-O-[4,6-O-2-thenylidene-ß-D-glucopyranosyl]epipodophyllotoxin and 4'-O-demethyl-1-O-]4, 6-O-ethylidene-ß-D-glucopyranosyl]epipodophyllotoxin exhibited qualitatively identical actions. On the other hand, of the other agents only X-rays exerted some effects comparable to those of the epipodophyllotoxins. We thus conclude that, of the drugs tested, 4'-O-demethyl-1-O-[4,6-O-2-thenylidene-ß-D-glucopyranosyl]epipodophyllotoxin and 4'-O-demethyl-1-O-[4,6-O-ethylidene-ß-D-glucopyranosyl]epipodophyllotoxin possess a unique mechanism of action.

1 To whom requests for reprints should be addressed.

Received 7/ 6/76. Accepted 5/27/77.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.